The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Raf kinases in cancer–roles and therapeutic opportunities
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M.-K., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,192
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M., & Rosen, N. (2010) · Nature · doi:10.1038/nature08902 · Cited by 1,811
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Hatzivassiliou, G., Song, K., Yen, I., Brandhuber, B. J., Anderson, D. J., Alvarado, R., Ludlam, M. J. C., Stokoe, D., Gloor, S. L., Vigers, G., et al. (2010) · Nature · doi:10.1038/nature08833 · Cited by 1,622
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Heidorn, S. J., Milagre, C., Whittaker, S., Nourry, A., Niculescu-Duvas, I., Dhomen, N., Hussain, J., Reis-Filho, J. S., Springer, C. J., Pritchard, C., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.040 · Cited by 1,465
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711741105 · Cited by 1,346
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324 · cited 1×
“More recently, the list has been revised to include other features of cancer cells related to their interaction with the environment, such as avoidance of immunosurveillance (Dunn et al., 2004; Smyth et al., 2006; Zitvogel et al., 2006) and the stress phenotypes of cancer (Luo et al.”
BackgroundAcute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z.-Y., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,277
Villanueva, J., Vultur, A., Lee, J. T., Somasundaram, R., Fukunaga-Kalabis, M., Cipolla, A. K., Wubbenhorst, B., Xu, X., Gimotty, P. A., Kee, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.023 · Cited by 1,259
The RAF proteins take centre stage
Wellbrock, C., Karasarides, M., & Marais, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1498 · Cited by 1,228
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Sahai, E., & Marshall, C. J. (2003) · Nature Cell Biology · doi:10.1038/ncb1019 · Cited by 1,147
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
Kolch, W. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1743 · Cited by 1,070
Jones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Bäcklund, L. M., Ichimura, K., & Collins, V. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2097 · Cited by 944
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Senescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
Tidyman, W. E., & Rauen, K. A. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.001 · Cited by 780
Boni, A., Cogdill, A. P., Dang, P., Udayakumar, D., Njauw, C.-N. J., Sloss, C. M., Ferrone, C. R., Flaherty, K. T., Lawrence, D. P., Fisher, D. E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0118 · Cited by 742
Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis
Janda, E., Lehmann, K., Killisch, I., Jechlinger, M., Herzig, M., Downward, J., Beug, H., & Grünert, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109037 · Cited by 706
The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
Sumimoto, H., Imabayashi, F., Iwata, T., & Kawakami, Y. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051848 · Cited by 698
Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639
Weisberg, E., Manley, P. W., Cowan-Jacob, S. W., Hochhaus, A., & Griffin, J. D. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2126 · Cited by 636
Regulation of Raf-1 by Direct Feedback Phosphorylation
Dougherty, M. K., Müller, J., Ritt, D. A., Zhou, M., Zhou, X. Z., Copeland, T. D., Conrads, T. P., Veenstra, T. D., Lu, K. P., & Morrison, D. K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.055 · Cited by 633
Integrating signals from RTKs to ERK/MAPK
McKay, M. M., & Morrison, D. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210394 · Cited by 621
Pratilas, C. A., Taylor, B. S., Ye, Q., Viale, A., Sander, C., Solit, D. B., & Rosen, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900780106 · Cited by 614
Chan, S. R. W. L., & Blackburn, E. H. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1370 · Cited by 595
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Dhomen, N., Reis-Filho, J. S., da Rocha Dias, S., Hayward, R., Savage, K., Delmas, V., Larue, L., Pritchard, C., & Marais, R. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.022 · Cited by 594
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Pfister, S., Janzarik, W. G., Remke, M., Ernst, A., Werft, W., Becker, N., Toedt, G., Wittmann, A., Kratz, C., Olbrich, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33656 · Cited by 523
A dimerization-dependent mechanism drives RAF catalytic activation
Rajakulendran, T., Sahmi, M., Lefrançois, M., Sicheri, F., & Therrien, M. (2009) · Nature · doi:10.1038/nature08314 · Cited by 489
Tumour cell survival signalling by the ERK1/2 pathway
Balmanno, K., & Cook, S. J. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.148 · Cited by 484
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.
Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., & Stephenson, J. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4218 · Cited by 483
Dankort, D., Filenova, E., Collado, M., Serrano, M., Jones, K., & McMahon, M. (2007) · Genes & Development · doi:10.1101/gad.1516407 · Cited by 481
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Palanisamy, N., Ateeq, B., Kalyana-Sundaram, S., Pflueger, D., Ramnarayanan, K., Shankar, S., Han, B., Cao, Q., Cao, X., Suleman, K., et al. (2010) · Nature Medicine · doi:10.1038/nm.2166 · Cited by 464
High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1
Sewing, A., Wiseman, B., Lloyd, A. C., & Land, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5588 · Cited by 462
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
Ciampi, R., Knauf, J. A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M. N., Rabes, H. M., Fagin, J. A., & Nikiforov, Y. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523237 · Cited by 461
Joseph, E. W., Pratilas, C. A., Poulikakos, P. I., Tadi, M., Wang, W., Taylor, B. S., Halilovic, E., Persaud, Y., Xing, F., Viale, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008990107 · Cited by 449
Regulation and Role of Raf-1/B-Raf Heterodimerization
Rushworth, L. K., Hindley, A. D., O'Neill, E., & Kolch, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2262-2272.2006 · Cited by 418
Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., & O'Neill, E. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.008 · Cited by 416
Self-citationWild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving Heterodimerization
Garnett, M. J., Rana, S., Paterson, H., Barford, D., & Marais, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.022 · Cited by 416
Chang, C.-J., Yang, J.-Y., Xia, W., Chen, C.-T., Xie, X., Chao, C.-H., Woodward, W. A., Hsu, J.-M., Hortobagyi, G. N., & Hung, M.-C. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.035 · Cited by 408
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D., & Bennett, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603283 · Cited by 394
Examination of Mutations in BRAF, NRAS, and PTEN in Primary Cutaneous Melanoma
Goel, V. K., Lazar, A. J. F., Warneke, C. L., Redston, M. S., & Haluska, F. G. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700026 · Cited by 392
Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7
Dangi‐Garimella, S., Yun, J., Eves, E. M., Newman, M., Erkeland, S. J., Hammond, S. M., Minn, A. J., & Rosner, M. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.294 · Cited by 363
Zheng, B., Jeong, J. H., Asara, J. M., Yuan, Y.-Y., Granter, S. R., Chin, L., & Cantley, L. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.026 · Cited by 359
Opposing Effects of Ras on p53
Ries, S., Biederer, C., Woods, D., Shifman, O., Shirasawa, S., Sasazuki, T., McMahon, M., Oren, M., & McCormick, F. (2000) · Cell · doi:10.1016/s0092-8674(00)00123-9 · Cited by 357
Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli
Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G., & Cheresh, D. A. (2003) · Science · doi:10.1126/science.1082015 · Cited by 336
Jones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Ichimura, K., & Collins, V. P. (2009) · Oncogene · doi:10.1038/onc.2009.73 · Cited by 321
Mutant V599EB-Raf Regulates Growth and Vascular Development of Malignant Melanoma Tumors
Sharma, A., Trivedi, N. R., Zimmerman, M. A., Tuveson, D. A., Smith, C. D., & Robertson, G. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2423 · Cited by 321
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
O'Neill, E., Rushworth, L., Baccarini, M., & Kolch, W. (2004) · Science · doi:10.1126/science.1103233 · Cited by 317
Self-citationChen, J., Fujii, K., Zhang, L., Roberts, T., & Fu, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141224398 · Cited by 316
Active Ras induces heterodimerization of cRaf and BRaf.
Weber, C., Slupsky, J. R., Kalmes, H. A., & Rapp, U. R. (2001) · PubMed · Cited by 312
Nicotine induces cell proliferation by -arrestin-mediated activation of Src and Rb-Raf-1 pathways
Dasgupta, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28164 · Cited by 311
Dumaz, N., Hayward, R., Martin, J., Ogilvie, L., Hedley, D., Curtin, J. A., Bastian, B. C., Springer, C., & Marais, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4227 · Cited by 304
Lehmann, K., Janda, E., Pierreux, C. E., Rytömaa, M., Schulze, A., McMahon, M., Hill, C. S., Beug, H., & Downward, J. (2000) · Genes & Development · doi:10.1101/gad.181700 · Cited by 287
Kefford, R., Arkenau, H., Brown, M. P., Millward, M., Infante, J. R., Long, G. V., Ouellet, D., Curtis, M., Lebowitz, P. F., & Falchook, G. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.8503 · Cited by 275
Riesco-Eizaguirre, G., Rodríguez, I., De la Vieja, A., Costamagna, E., Carrasco, N., Nistal, M., & Santisteban, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1248 · Cited by 265
Analysis of the transcriptional program induced by Raf in epithelial cells
Schulze, A., Lehmann, K., Jefferies, H. B. J., McMahon, M., & Downward, J. (2001) · Genes & Development · doi:10.1101/gad.191101 · Cited by 259
Mutant BRAF Melanomas—Dependence and Resistance
Poulikakos, P. I., & Rosen, N. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.008 · Cited by 250
Serine- and threonine-specific protein kinase activities of purified gag–mil and gag–raf proteins
Moelling, K., Heimann, B., Beimling, P., Rapp, U. R., & Sander, T. (1984) · Nature · doi:10.1038/312558a0 · Cited by 240
Impact of Feedback Phosphorylation and Raf Heterodimerization on Normal and Mutant B-Raf Signaling
Ritt, D. A., Monson, D. M., Specht, S. I., & Morrison, D. K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00569-09 · Cited by 238
Mitsutake, N., Knauf, J. A., Mitsutake, S., Mesa, C., Zhang, L., & Fagin, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3314 · Cited by 228
Pritchard, C. A., Samuels, M. L., Bosch, E., & McMahon, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6430 · Cited by 224
p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis
Han, J. A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf591 · Cited by 214
Gene amplifications associated with the development of hormone-resistant prostate cancer.
Edwards, J., Krishna, N. S., Witton, C. J., & Bartlett, J. M. S. (2003) · PubMed · Cited by 213
Arozarena, I., Sanchez-Laorden, B., Packer, L., Hidalgo-Carcedo, C., Hayward, R., Viros, A., Sahai, E., & Marais, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.029 · Cited by 212
Emuss, V., Garnett, M., Mason, C., The Cancer Genome Project, & Marais, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1683 · Cited by 207
Raf-1 regulates Rho signaling and cell migration
Ehrenreiter, K., Piazzolla, D., Velamoor, V., Sobczak, I., Small, J. V., Takeda, J., Leung, T., & Baccarini, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409162 · Cited by 207
Self-citationZhuang, D., Mannava, S., Grachtchouk, V, Tang, W.-H., Patil, S., Wawrzyniak, J. A., Berman, A. E., Giordano, T. J., Prochownik, E. V., Soengas, M. S., et al. (2008) · Oncogene · doi:10.1038/onc.2008.258 · Cited by 203
Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
Cheung, M., Sharma, A., Madhunapantula, S. V., & Robertson, G. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5867 · Cited by 196
Golding, S. E., Rosenberg, E., Neill, S., Dent, P., Povirk, L. F., & Valerie, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2371 · Cited by 189
Kasid, U., Pfeifer, A., Brennan, T., Beckett, M., Weichselbaum, R. R., Dritschilo, A., & Mark, G. E. (1989) · Science · doi:10.1126/science.2466340 · Cited by 186
A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal
Catalanotti, F., Reyes, G., Jesenberger, V., Galabova-Kovacs, G., de Matos Simoes, R., Carugo, O., & Baccarini, M. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1564 · Cited by 182
Self-citationRaf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation
Baumann, B., Weber, C. K., Troppmair, J., Whiteside, S., Israel, A., Rapp, U. R., & Wirth, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080583397 · Cited by 177
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice
Goel, V. K., Ibrahim, N., Jiang, G., Singhal, M., Fee, S., Flotte, T., Westmoreland, S., Haluska, F. S., Hinds, P. W., & Haluska, F. G. (2009) · Oncogene · doi:10.1038/onc.2009.95 · Cited by 165
Simon, R., Richter, J., Wagner, U. A., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R. E., Alund, G., Knönagel, H., et al. (2001) · PubMed · Cited by 162
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor
Granovsky, A. E., & Rosner, M. R. (2008) · Cell Research · doi:10.1038/cr.2008.43 · Cited by 162
Targeting BRAF for patients with melanoma
Arkenau, H., Kefford, R. F., & Long, G. V. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606030 · Cited by 159
Raf Kinase Inhibitory Protein Regulates Aurora B Kinase and the Spindle Checkpoint
Eves, E. M., Shapiro, P. S., Naik, K., Klein, U. R., Trakul, N., & Rosner, M. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.07.015 · Cited by 158
Activation of Raf by ionizing radiation
Kasid, U. N., Suy, S., Dent, P., Ray, S., Whiteside, T. L., & Sturgill, T. W. (1996) · Nature · doi:10.1038/382813a0 · Cited by 153
Mutant V600E BRAF Increases Hypoxia Inducible Factor-1α Expression in Melanoma
Kumar, S., Yu, H., Edwards, R. H., Chen, L., Kazianis, S., Brafford, P. A., Ács, G., Herlyn, M., & Xu, X. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3312 · Cited by 147
The raf Oncogene Is Associated with a Radiation-Resistant Human Laryngeal Cancer
Kasid, U. N., Pfeifer, A., Weichselbaum, R. R., Dritschilo, A., & Mark, G. E. (1987) · Science · doi:10.1126/science.3616625 · Cited by 145
Carragher, L. A. S., Snell, K. R., Giblett, S. M., Aldridge, V. S. S., Patel, B., Cook, S. J., Winton, D. J., Marais, R., & Pritchard, C. A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000099 · Cited by 144
Goueli, B. S., & Janknecht, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.25-35.2004 · Cited by 144
Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma*1
Hwang, Y. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.02.009 · Cited by 143
Activated Raf-1 causes growth arrest in human small cell lung cancer cells.
Ravi, R. K., Weber, E., McMahon, M., Williams, J. R., Baylin, S. B., Mal, A., Harter, M. L., Dillehay, L. E., Claudio, P. P., Giordano, A., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci831 · Cited by 142
Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma
Old, W. M., Shabb, J. B., Houel, S., Wang, H., Couts, K. L., Yen, C.-Y., Litman, E. S., Croy, C. H., Meyer-Arendt, K., Miranda, J. G., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.007 · Cited by 137
Targets of Raf in tumorigenesis
Niault, T., & Baccarini, M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp337 · Cited by 137
Self-citationRAF inhibition and induction of cutaneous squamous cell carcinoma
Robert, C., Arnault, J., & Mateus, C. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283436e8c · Cited by 119
Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target
Zeng, L., Imamoto, A., & Rosner, M. R. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1275 · Cited by 119
Wang, S., Ghosh, R. N., & Chellappan, S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7487 · Cited by 118
Sharma, A. K., Tran, M. A., Liang, S., Sharma, A. K., Amin, S., Smith, C. D., Dong, C., & Robertson, G. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0809 · Cited by 112
Park, B.-J., Park, J., Byun, D.-S., Park, J. H., & Chi, S. G. (2000) · PubMed · Cited by 109
Raf-1 Addiction in Ras-Induced Skin Carcinogenesis
Ehrenreiter, K., Kern, F., Velamoor, V., Meissl, K., Galabova‐Kovacs, G., Sibilia, M. C., & Baccarini, M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.008 · Cited by 106
Self-citationKerkhoff, E., Fedorov, L. M., Siefken, R., Walter, A. O., Papadopoulos, T. G., & Rapp, U. R. (2000) · PubMed · Cited by 105
B-Raf Acts via the ROCKII/LIMK/Cofilin Pathway To Maintain Actin Stress Fibers in Fibroblasts
Pritchard, C. A., Hayes, L., Wojnowski, L., Zimmer, A., Marais, R., & Norman, J. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5937-5952.2004 · Cited by 105
Beliveau, A., Mott, J. D., Lo, A. T., Chen, E. I., Koller, A. A., Yaswen, P., Muschler, J. L., & Bissell, M. J. (2010) · Genes & Development · doi:10.1101/gad.1990410 · Cited by 103
Dai, Y., Chen, S., Pei, X., Almenara, J. A., Kramer, L. B., Venditti, C. A., Dent, P., & Grant, S. (2008) · Blood · doi:10.1182/blood-2008-05-159392 · Cited by 102
Disruption of the Rb-Raf-1 Interaction Inhibits Tumor Growth and Angiogenesis
Dasgupta, P., Sun, J., Wang, S., Fusaro, G., Betts, V., Padmanabhan, J., Sebti, S. M., & Chellappan, S. P. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9527-9541.2004 · Cited by 98
B-RAF Regulation of Rnd3 Participates in Actin Cytoskeletal and Focal Adhesion Organization
Klein, R. M., Spofford, L. S., Abel, E. V., Ortiz, A. E., & Aplin, A. E. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0895 · Cited by 92
Takezawa, K., Okamoto, I., Yonesaka, K., Hatashita, E., Yamada, Y., Fukuoka, M., & Nakagawa, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1076 · Cited by 91
Zebisch, A., Staber, P. B., Delavar, A., Bodner, C., Hiden, K., Fischereder, K., Janakiraman, M., Linkesch, W., Auner, H. W., Emberger, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0115 · Cited by 90
Alavi, A., Acevedo, L. M., Wang, M., & Cheresh, D. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3648 · Cited by 88
Yu, H., McDaid, R., Lee, J., Possik, P. A., Li, L., Kumar, S. M., Elder, D. E., Belle, P. A. V., Gimotty, P. A., Guerra, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081057 · Cited by 85
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-α signaling
Piazzolla, D., Meissl, K., Kučerová, L., Rubiolo, C., & Baccarini, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504137 · Cited by 85
Self-citationDessars, B., Raeve, L. E. D., Housni, H. E., Debouck, C., Sidon, P. J., Morandini, R., Roseeuw, D. I., Ghanem, G., Vassart, G., & Heimann, P. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700725 · Cited by 84
Ceteci, F., Ceteci, S., Karreman, C., Kramer, B. W. W., Asan, E., Götz, R., & Rapp, U. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.014 · Cited by 83
Liang, S., Sharma, A. K., Peng, H., Robertson, G. P., & Dong, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4233 · Cited by 82
B-RafV600E Cooperates With Alternative Spliced Rac1b to Sustain Colorectal Cancer Cell Survival
Matos, P., Oliveíra, C., Velho, S., Gonçalves, V., da Costa, L. T., Moyer, M. P., Seruca, R., & Jordan, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.052 · Cited by 78
Transcriptional regulation of telomerase activity: Roles of the the Ets transcription factor family
DWYER, J., LI, H., XU, D., & LIU, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.022 · Cited by 77
Constitutive Activation of Raf-1 Induces Glioma Formation in Mice
Lyustikman, Y., Momota, H., Pao, W. J., & Holland, E. C. (2008) · Neoplasia · doi:10.1593/neo.08206 · Cited by 73
Schulze, A., Nicke, B., Warne, P. H., Tomlinson, S. R., & Downward, J. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0807 · Cited by 72
C-Raf Inhibits MAPK Activation and Transformation by B-RafV600E
Karreth, F. A., DeNicola, G. M., Winter, S. P., & Tuveson, D. A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.017 · Cited by 64
Calipel, A., Mouriaux, F., Glotin, A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600228200 · Cited by 59
The TGFß pathway as a therapeutic target in cancer
Seoane, J. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0148-2 · Cited by 59
p19ARF‐independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes
Roper, E. A., Weinberg, W. C., Watt, F. M., & Land, H. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve020 · Cited by 59
Identification of Novel in Vivo Phosphorylation Sites of the Human Proapoptotic Protein BAD
Polzien, L., Baljuls, A., Rennefahrt, U. E. E., Fischer, A., Schmitz, W., Zahedi, R. P., Sickmann, A., Metz, R., Albert, S., Benz, R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010702 · Cited by 58
Argast, G. M., Croy, C. H., Couts, K. L., Zhang, Z., Litman, E. S., Chan, D. C. F., & Ahn, N. G. (2009) · Oncogene · doi:10.1038/onc.2009.133 · Cited by 57
Partner exchange: protein–protein interactions in the Raf pathway
Wimmer, R., & Baccarini, M. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.06.001 · Cited by 57
Self-citationBRAF Inactivation Drives Aneuploidy by Deregulating CRAF
Kamata, T., Hussain, J., Giblett, S. M., Hayward, R., Marais, R., & Pritchard, C. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0603 · Cited by 49
Kramer, B. W. W., Götz, R., & Rapp, U. R. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-24 · Cited by 48
Kinkade, R., Dasgupta, P., Carie, A., Pernazza, D., Carless, M. A., Pillai, S., Lawrence, N. J., Sebti, S. M., & Chellappan, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6672 · Cited by 48
Troppmair, J., Hartkamp, J., & Rapp, U. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201981 · Cited by 48
Survival Signaling by C-RAF: Mitochondrial Reactive Oxygen Species and Ca2+ Are Critical Targets
Kuznetsov, A. V., Smigelskaite, J., Doblander, C., Janakiraman, M., Hermann, M., Wurm, M., Scheidl, S. F., Sucher, R., Deutschmann, A. J., & Troppmair, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00683-07 · Cited by 45
Biological challenges of BRAF inhibitor therapy
Puzanov, I. J., Burnett, P., & Flaherty, K. T. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.01.005 · Cited by 40
Marx, M., Eychène, A., Laugier, D., Béchade, C., Crisanti, P., Dezélée, P., Pessac, B., & Calothy, G. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03209.x · Cited by 39
Oxidative Stress Plays a Critical Role in Inactivating Mutant BRAF by Geldanamycin Derivatives
Fukuyo, Y., Inoue, M., Nakajima, T., Higashikubo, R., Horikoshi, N. T., Hunt, C. R., Usheva, A., Freeman, M. L., & Horikoshi, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6602 · Cited by 39
Raf-induced transformation requires an interleukin 1 autocrine loop.
Vale, T., Ngo, T.-T. B., White, M. A., & Lipsky, P. E. (2001) · PubMed · Cited by 31
Zebisch, A., Haller, M., Hiden, K., Goebel, T. E., Höefler, G., Troppmair, J., & Sill, H. (2009) · Leukemia · doi:10.1038/leu.2009.68 · Cited by 30
Fedorov, L. M., Papadopoulos, T., Tyrsin, O. Y., Twardzik, T., Götz, R., & Rapp, U. R. (2003) · PubMed · Cited by 28
Bcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf.
Fedorov, L. M., Tyrsin, O. Y., Papadopoulos, T., Camarero, G., Götz, R., & Rapp, U. R. (2002) · PubMed · Cited by 26
Fan, S., Meng, Q., Laterra, J., & Rosen, E. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210271 · Cited by 25
Sobczak, I., Galabova‐Kovacs, G., Sadzak, I., Kren, A., Christofori, G., & Baccarini, M. (2008) · Oncogene · doi:10.1038/onc.2008.128 · Cited by 21
Self-citationWang, X., Thomson, S. R., Starkey, J. D., Page, J. L., Ealy, A. D., & Johnson, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306489200 · Cited by 13
Cited by
ERK1/2 MAP kinases: Structure, function, and regulation
Roskoski, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,650
Kinase-targeted cancer therapies: progress, challenges and future directions
Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0804-2 · Cited by 1,245
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Bahar, M. E., Kim, H. J., & Kim, D. R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01705-z · Cited by 888
The role of BRAF V600 mutation in melanoma
Ascierto, P. A., Kirkwood, J. M., Grob, J.-J., Simeone, E., Grimaldi, A. M., Maio, M., Palmieri, G., Testori, A., Marincola, F. M., & Mozzillo, N. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-85 · Cited by 801
Metadata
- Authors
- Maurer, G., Tarkowski, B., & Baccarini, M.
- Venue
- Oncogene
- Published
- 2011-05-16
- Volume
- 30
- Issue
- 32
- Pages
- 3477-3488
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2079216025
- Cited by
- 292
- References
- 145
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.